Cyclic acetal hydroxyapatite composites and endogenous osteogenic gene expression of rat marrow stromal cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 4, Issue 6, 2010, Pages 422-436

  Patel, Minal ^a   Dunn, Thomas A ^a   Tostanoski, Sarah ^a   Fisher, John P ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Bone; Composite; Cyclic acetal; Hydroxyapatite; Tissue engineering

Indexed keywords

BONE; CELL ENGINEERING; CYTOLOGY; FLOW CYTOMETRY; GENE EXPRESSION; HYDROXYAPATITE; SCREENING; TISSUE ENGINEERING;

BONE GROWTH; BONE MARROW STROMAL CELLS; CELL-BE; CELL/B.E; CYCLIC ACETALS; GROWTH FACTOR; HYDROXYAPATITE COMPOSITE; HYDROXYAPATITE PARTICLES; OSTEOGENIC; TISSUES ENGINEERINGS;

MOLECULES;

ACETAL; AGGRECAN; ALKALINE PHOSPHATASE; BETA1 INTEGRIN; CD51 ANTIGEN; CD61 ANTIGEN; COLLAGENASE 3; DENTIN MATRIX PROTEIN 1; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; HYDROXYAPATITE; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR A; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STROMA CELL; UPREGULATION;

EID: 77956841770     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.252     Document Type: Article

References (64)

1. Akiyama SK. 1996; Integrins in cell adhesion and signaling. Hum Cell 9: 181-186.
2. Alison MR, Brittan M, Lovell MJ, et al. 2006; Markers of adult tissue-based stem cells. Handb Exp Pharmacol 174: 185-227.
3. Alison MR, Islam S. 2009; Attributes of adult stem cells. J Pathol 217: 144-160.
4. Arnold U, Schweitzer S, Lindenhayn K, et al. 2003; Optimization of bone engineering by means of growth factors in a three-dimensional matrix. J Biomed Mater Res A 67: 260-269.
5. Betz MW, Modi PC, Caccamese JF, et al. 2008; Cyclic acetal hydrogel system for bone marrow stromal cell encapsulation and osteodifferentiation. J Biomed Mater Res A 86: 662-670.
6. Bigi A, Nicoli-Aldini N, Bracci B, et al. 2007; In vitro culture of mesenchymal cells onto nanocrystalline hydroxyapatite-coated Ti13Nb13Zr alloy. J Biomed Mater Res A 82: 213-221.
7. Birk RZ, Abramovitch-Gottlib L, Margalit I, et al. 2006; Conversion of adipogenic to osteogenic phenotype using crystalline porous biomatrices of marine origin. Tissue Eng 12: 21-31.
8. Boanini E, Torricelli P, Gazzano M, et al. 2006; Nanocomposites of hydroxyapatite with aspartic acid and glutamic acid and their interaction with osteoblast-like cells. Biomaterials 27: 4428-4433.
9. Bonewald LF, Mundy GR. 1990; Role of transforming growth factor-β in bone remodeling. Clin Orthop Relat Res 250: 261-276.
10. Boskey AL. 1995; Osteopontin and related phosphorylated sialoproteins: effects on mineralization. Ann N Y Acad Sci 760: 249-256.
11. Boyce BF, Hughes DE, Wright KR, et al. 1999; Recent advances in bone biology provide insight into the pathogenesis of bone diseases. Lab Invest 79: 83-94.
12. Braun N. 1997; Expression of adhesion molecules and activation markers on lymphocytes and monocytes during hemodialysis. Blood Purif 15: 61-76.
13. Butler WT. 1989; The nature and significance of osteopontin. Connect Tissue Res 23: 123-136.
14. Castaldini A, Cavallini A. 1985; Setting properties of bone cement with added synthetic hydroxyapatite. Biomaterials 6: 55-60.
15. Chicurel ME, Chen CS, Ingber DE. 1998; Cellular control lies in the balance of forces. Curr Opin Cell Biol 10: 232-239.
16. Choi KY, Kim HJ, Lee MH, et al. 2005; Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development. Dev Dyn 233: 115-121.
17. Christenson RH. 1997; Biochemical markers of bone metabolism: an overview. Clin Biochem 30: 573-593.
18. Clement LT. 1992; Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation. J Clin Immunol 12: 1-10.
19. Coulombel L, Auffray I, Gaugler MH, et al. 1997; Expression and function of integrins on hematopoietic progenitor cells. Acta Haematol 97: 13-21.
20. Everts V, Delaisse JM, Korper W, et al. 1992; Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J Cell Physiol 150: 221-231.
21. Falco EE, Patel M, Fisher JP. 2008; Recent developments in cyclic acetal biomaterials for tissue engineering applications. Pharm Res 25: 2348-2356.
22. Franceschi RT. 2005; Biological approaches to bone regeneration by gene therapy. J Dent Res 84: 1093-1103.
23. Friedman CD, Costantino PD, Takagi S, et al. 1998; BoneSource hydroxyapatite cement: a novel biomaterial for craniofacial skeletal tissue engineering and reconstruction. J Biomed Mater Res 43: 428-432.
24. Gronowicz G, McCarthy MB. 1996; Response of human osteoblasts to implant materials: integrin-mediated adhesion. J Orthop Res 14: 878-887.
25. Haas R, Baron M, Zechner W, et al. 2003; Porous hydroxyapatite for grafting the maxillary sinus in sheep: comparative pullout study of dental implants. Int J Oral Maxillofac Implants 18: 691-696.
26. Holliday LS, Welgus HG, Fliszar CJ, et al. 1997; Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 272: 22053-22058.
27. Huang J, Lin YW, Fu XW, et al. 2007; Development of nanosized hydroxyapatite reinforced composites for tissue engineering scaffolds. J Mater Sci Mater Med 18: 2151-2157.
28. Huang JI, Zuk PA, Jones NF, et al. 2004; Chondrogenic potential of multipotential cells from human adipose tissue. Plast Reconstr Surg 113: 585-594.
29. Jin QM, Takita H, Kohgo T, et al. 2000; Effects of geometry of hydroxyapatite as a cell substratum in BMP-induced ectopic bone formation. J Biomed Mater Res 51: 491-499.
30. Kaihara S, Matsumura S, Fisher JP. 2008; Synthesis and characterization of cyclic acetal based degradable hydrogels. Eur J Pharm Biopharm 68: 67-73.
31. Kamalia N, McCulloch CA, Tenenbaum HC, et al. 1992; Direct flow cytometric quantification of alkaline phosphatase activity in rat bone marrow stromal cells. J Histochem Cytochem 40: 1059-1065.
32. Katagiri T, Takahashi N. 2002; Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8: 147-159.
33. Kells AF, Coats SR, Schwartz HS, et al. 1995; TGFβ and PDGF act synergistically in affecting the growth of human osteoblast-enriched cultures. Connect Tissue Res 31: 117-124.
34. Kido H, Saha S. 1996; Effect of HA coating on the long-term survival of dental implant: a review of the literature. J Long Term Eff Med Implant 6: 119-133.
35. Kreke MR, Goldstein AS. 2004; Hydrodynamic shear stimulates osteocalcin expression but not proliferation of bone marrow stromal cells. Tissue Eng 10: 780-788.
36. Kim DH, Yoo KH, Yim YS, et al. 2006; Co-transplanted bone marrow-derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice. J Korean Med Sci 21: 1000-1004.
37. Malaval L, Modrowski D, Gupta AK, et al. 1994; Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J Cell Physiol 158: 555-572.
38. Marie PJ, Fromigue O. 2006; Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen Med 1: 539-548.
39. Matsumoto T, Okazaki M, Nakahira A, et al. 2007; Modification of apatite materials for bone tissue engineering and drug delivery carriers. Curr Med Chem 14: 2726-2733.
40. McCulloch CA, Strugurescu M, Hughes F, et al. 1991; Osteogenic progenitor cells in rat bone marrow stromal populations exhibit self-renewal in culture. Blood 77: 1906-1911.
41. Mulari MT, Qu Q, Harkonen PL, et al. 2004; Osteoblast-like cells complete osteoclastic bone resorption and form new mineralized bone matrix in vitro. Calcif Tissue Int 75: 253-261.
42. Nair MB, Varma HK, John A. 2009; Platelet-rich plasma and fibrin glue-coated bioactive ceramics enhance growth and differentiation of goat bone marrow-derived stem cells. Tissue Eng A 15: 1619-1631.
43. Ohgushi H, Dohi Y, Katuda T, et al. 1996; In vitro bone formation by rat marrow cell culture. J Biomed Mater Res 32: 333-340.
44. Ong JL, Carnes DL, Sogal A. 1999; Effect of transforming growth factor-β on osteoblast cells cultured on three different hydroxyapatite surfaces. Int J Oral Maxillofac Implants 14: 217-225.
45. Reincke U, Hsieh P, Mauch P, et al. 1982; Cell types associated with fibronectin in long-term mouse bone marrow cultures. J Histochem Cytochem 30: 235-244.
46. Rodan GA, Noda M. 1991; Gene expression in osteoblastic cells. Crit Rev Eukaryot Gene Expr 1: 85-98.
47. Schilephake H. 2002; Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 31: 469-484.
48. Schwartz Z, Lohmann CH, Oefinger J, et al. 1999; Implant surface characteristics modulate differentiation behavior of cells in the osteoblastic lineage. Adv Dent Res 13: 38-48.
49. Shimizu-Sasaki E, Yamazaki M, Furuyama S, et al. 2003; Identification of FGF2-response element in the rat bone sialoprotein gene promoter. Connect Tissue Res 44(suppl 1): 103-108.
50. Sinha RK, Tuan RS. 1996; Regulation of human osteoblast integrin expression by orthopedic implant materials. Bone 18: 451-457.
51. Sohn SH, Jun HK, Kim CS, et al. 2006; Biological responses in osteoblast-like cell line according to thin layer hydroxyapatite coatings on anodized titanium. J Oral Rehabil 33: 898-911.
52. Sun H, Ye F, Wang J, et al. 2008; The upregulation of osteoblast marker genes inmesenchymal stem cells prove the osteoinductivity of hydroxyapatite/tricalcium phosphate biomaterial. Transpl Proc 40: 2645-2648.
53. Suzuki O, Kamakura S, Katagiri T, et al. 2006; Bone formation enhanced by implanted octacalcium phosphate involving conversion into Ca-deficient hydroxyapatite. Biomaterials 27: 2671-2681.
54. Tan Y, Wang G, Fan H, et al. 2007; Expression of core binding factor 1 and osteoblastic markers in C2C12 cells induced by calcium phosphate ceramics in vitro. J Biomed Mater Res A 82: 152-159. (Pubitemid 46906501)
55. + hematopoietic stem cells. Stem Cells 24: 1087-1094.
56. Wahl DA, Czernuszka JT. 2006; Collagen-hydroxyapatite composites for hard tissue repair. Eur Cell Mater 11: 43-56.
57. Wei G, Ma PX. 2004; Structure and properties of nanohydroxyapatite/ polymer composite scaffolds for bone tissue engineering. Biomaterials 25: 4749-4757.
58. Yoshikawa H, Myoui A. 2005; Bone tissue engineering with porous hydroxyapatite ceramics. J Artif Organs 8: 131-136.
59. Yoshikawa T, Ohgushi H, Dohi Y, et al. 1997; Viable bone formation in porous hydroxyapatite: marrow cell-derived in vitro bone on the surface of ceramics. Biomed Mater Eng 7: 49-58.
60. Yu X, Hsieh SC, Bao W, et al. 1997; Temporal expression of PDGF receptors and PDGF regulatory effects on osteoblastic cells in mineralizing cultures. Am J Physiol 272: C1709-1716.
61. Zeltser C, Masella R, Cholewa J, et al. 1989; Surgical and prosthodontic residual ridge reconstruction with hydroxyapatite. J Prosthet Dent 62: 441-448.
62. Zhou HY. 2007; Proteomic analysis of hydroxyapatite interaction proteins in bone. Ann N Y Acad Sci 1116: 323-326.
63. Zou L, Lv N, Feng W. 2007; Characteristics of osteoblastic differentiation in mesenchymal stem cells from porcine bone marrow in vitro. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 21: 1222-1227.
64. Zuckerman KS, Wicha MS. 1983; Extracellular matrix production by the adherent cells of long-term murine bone marrow cultures. Blood 61: 540-547.